Taurodeoxycholic acid sodium hydrate

Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate) prevents apoptosis by blocking a calcium-mediated apoptotic pathway as well as caspase-12 activation. Taurodeoxycholic acid sodium hydrate is investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis.

Price Not Available 100mg Taurodeoxycholic acid sodium hydrate Supplier Page

Trivial name	Sodium taurodeoxycholate monohydrate
Catalog Number	CSN27386
Alternative Name(s)	Sodium taurodeoxycholate monohydrate
Research Area	/
Molecular Formula	C26H46NNaO7S
CAS#	110026-03-4
Purity	≥95%
SMILES	C[C@]12[C@@H](O)C[C@@]3([C@@]4(C)CC[C@@H](O)C[C@]4(CC[C@]3([C@@]1(CC[C@@]2([C@@H](CCC(NCCS([O-])(=O)=O)=O)C)[H])[H])[H])[H])[H].[H]O[H].[Na+]
Size	100mg
Supplier Page	https://www.csnpharm.com/products/sodium-taurodeoxycholate-monohydrate.html